Evaluation of Immune Checkpoints in Canine Mast Cell Tumours: PD-L1 and CD86 Are Overexpressed in Cutaneous Mast Cell Tumours

MLA

L. Bertola, et al. “Evaluation of Immune Checkpoints in Canine Mast Cell Tumours: PD-L1 and CD86 Are Overexpressed in Cutaneous Mast Cell Tumours.” Journal of Comparative Pathology, vol. 191, Feb. 2022, p. 15. EBSCOhost, https://doi.org/10.1016/j.jcpa.2021.11.034.

APA

L. Bertola, M. Sarzì Amadei, R. Ferrari, L.E. Chiti, D. Stefanello, M. Manfredi, D. De Zani, C. Giudice, G. Valeria, F. Ceciliani, C. Lecchi, & C. Recordati. (2022). Evaluation of Immune Checkpoints in Canine Mast Cell Tumours: PD-L1 and CD86 Are Overexpressed in Cutaneous Mast Cell Tumours. Journal of Comparative Pathology, 191, 15. https://doi.org/10.1016/j.jcpa.2021.11.034

Chicago

L. Bertola, M. Sarzì Amadei, R. Ferrari, L.E. Chiti, D. Stefanello, M. Manfredi, D. De Zani, et al. 2022. “Evaluation of Immune Checkpoints in Canine Mast Cell Tumours: PD-L1 and CD86 Are Overexpressed in Cutaneous Mast Cell Tumours.” Journal of Comparative Pathology 191 (February): 15. doi:10.1016/j.jcpa.2021.11.034.